Daniel BRAAS

City:

Madison, Wisconsin

Country:

United States

Published Applications:

Last publication date:

2026-01-08

Top Assignees for applications by Daniel BRAAS

The entities that hold a legal rights for patent applications filed by inventor BRAAS Daniel:

Arrowhead Pharmaceuticals, Inc. 4 Pasadena, CA United States

Recent patent applications by BRAAS Daniel

Daniel BRAAS from Madison, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-01-08

US20260009037A1

Chemistry; metallurgy

RNAi Agents for Inhibiting Expression of Mitochondrial Amidoxime Reducing Component 1 (MARC1), Pharmaceutical Compositions Thereof, and Methods of Use

#2 | 2025-03-06

US20250075214A1

Chemistry; metallurgy

RNAi Agents for Inhibiting Expression of Inhibin Subunit Beta E (INHBE), Pharmaceutical Compositions Thereof, and Methods of Use

#3 | 2024-06-27

US20240210423A1

Physics

DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDERS ASSOCIATED WITH ALTERED METABOLIC PATHWAYS

#4 | 2024-04-11

US20240118291A1

Physics

DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDERS USING ALTERED RATIOS OF METABOLIC CONCENTRATIONS

#5 | 2023-05-04

US20230139166A1

Chemistry; metallurgy

RNAi Agents for Inhibiting Expression of Xanthine Dehydrogenase (XDH), Pharmaceutical Compositions Thereof, and Methods of Use

#6 | 2023-04-27

US20230125671A1

Chemistry; metallurgy

RNAi Agents for Inhibiting Expression of Xanthine Dehydrogenase (XDH), Pharmaceutical Compositions Thereof, and Methods of Use

#7 | 2023-01-19

US20230013224A1

Chemistry; metallurgy

RNAi agents for inhibiting expression of xanthine dehydrogenase (XDH), pharmaceutical compositions thereof, and methods of use

#8 | 2023-01-05

US20230002773A1

Chemistry; metallurgy

RNAi agents for inhibiting expression of xanthine dehydrogenase (XDH), pharmaceutical compositions thereof, and methods of use

InventorID:

5622958 ⎘